2cureX AB (Sweden) Top Management

2CUREX Stock   1.34  -0.08  -5.63%   
2cureX AB employs about 14 people. The company is managed by 5 executives with a total tenure of roughly 33 years, averaging almost 6.0 years of service per executive, having 2.8 employees per reported executive. For 2cureX AB, management analysis can help investors test whether leadership decisions are reinforcing the broader investment thesis or creating new operating risk. Used properly, management analysis helps separate durable execution from results that may only reflect a supportive market cycle.
Kenneth Johansen  Insider
Chief Officer
Grith Hagel  Insider
COO CoFounder
  
Trending Equities provides context for diversified portfolio design. Additional portfolio transparency improves capital positioning. The allocation includes a position in 2cureX AB across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

2cureX AB Management Team Effectiveness

The company has return on total asset (ROA) of -29.72 % which means that it has lost $29.72 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of -44.73 %, meaning that it generated substantial loss on money invested by shareholders.

2cureX Stock Ownership Analysis

About 51.0% of the company shares are owned by insiders or employees . The book value of 2cureX AB was presently reported as 2.88. The company recorded a loss per share of 1.46. 2cureX AB had not issued any dividends in recent years. The entity completed a 1071:1012 stock split on 2nd of May 2019.

2cureX AB Outstanding Bonds

Reviewing 2cureX AB bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.
2cureX AB reflects a meaningful amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Approximately 0% of 2cureX AB's shares are held by institutions, 51% by insiders, and 48% by the general public.

2cureX Stock Holders Distribution

Institutional ownership analysis for 2cureX AB matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.

2cureX AB Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. 2cureX AB Price Series Summation is a cross summation of 2cureX AB price series and its benchmark/peer.

2cureX AB Notable Stakeholders

Stakeholders matter for 2cureX AB because not every influential participant is a shareholder acting with the same objective or time horizon. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
Kenneth JohansenChief OfficerProfile
Grith HagelCOO CoFounderProfile
Fernando AndreuChief OfficerProfile
Ole VDDeputy CoFounderProfile
Mark GrayDirector CommunicationsProfile

2cureX AB Management and Insider Overview

2cureX AB is a micro-cap company. Executive review focuses on insiders, senior management, and employee signals. Executive analysis adds context to whether current strategy is being executed with discipline. 2cureX AB is assessed in terms of its structural contribution to portfolio diversification and long-term stability.

Methodology

Unless otherwise specified, financial data for 2cureX AB is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. 2cureX (SE:2CUREX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Insider activity and ownership figures are derived from regulatory filings, including SEC Form 4 submissions where applicable.

Assumptions

Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

2cureX AB may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

2cureX AB Workforce Analysis

Investors reviewing 2cureX AB can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.

2cureX AB Manpower Efficiency

Return on 2cureX AB Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.4M
Net Loss Per Executive3.8M

Popular Tools for 2cureX Stock analysis

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital